CDEK
by
Data4ThePeople
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
Sign in
Sign up
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
← All drugs
Report issue
briobacept
Recombinant protein
experimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
Tumor necrosis factor ligand superfamily member 13B
INHIBITOR
TNFSF13B inhibitor
Tumor necrosis factor ligand superfamily member 13B
(TNFSF13B)
↗
Chemistry & pharmacology
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No
Oral
No
Parenteral
No
Topical
No
Sources
ChEMBL
CHEMBL2107844 ↗
Also known as
br-3-fc
briobacept
ss-79